Search clinical trials for: Placebo Fulvestrant
Total 54240 results
-
AstraZenecaActive, not recruitingAdvanced Metastatic Breast CancerUnited States
-
Atossa Therapeutics, Inc.TerminatedFemale Breast Carcinoma | Female Ductal Carcinoma In SituUnited States
-
M.D. Anderson Cancer CenterEli Lilly and Company; AstraZenecaActive, not recruitingMalignant Neoplasms of Female Genital OrgansUnited States
-
Calithera Biosciences, IncCompletedBreast NeoplasmsUnited States, Spain
-
AstraZenecaCompletedAdvanced Breast Cancer | Metastatic Breast CancerBelgium, Turkey, Canada, Poland, Romania, Hungary, France, Czechia
-
Biyun Wang, MDRecruiting
-
AstraZenecaCompletedAdvanced Breast Cancer | Metastatic Breast CancerJapan
-
Royal Marsden NHS Foundation TrustPfizer; AstraZeneca; Institute of Cancer Research, United Kingdom; UNICANCER; Gustave... and other collaboratorsRecruitingHER2-negative Breast Cancer | ER+ Breast CancerUnited Kingdom, France
-
M.D. Anderson Cancer CenterNot yet recruitingHormone Receptor-positive Human Epidermal Growth Factor 2-negative | Metastatic Invasive LObular CarcinomaUnited States
-
Tianjin Medical University Cancer Institute and...Not yet recruiting
-
University of Colorado, DenverUnited States Department of DefenseActive, not recruitingBreast CancerUnited States
-
Nuvation Bio Inc.WithdrawnBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Breast Carcinoma | Cancer of Breast | Malignant Tumor of Breast | Breast Tumor | Cancer of the BreastUnited States
-
Memorial Sloan Kettering Cancer CenterDebiopharm International SACompletedBreast CancerUnited States
-
Stanford UniversityAstraZenecaCompletedProstatic Neoplasms | Prostate CancerUnited States
-
AstraZenecaCompleted
-
The Center for Rheumatic Disease, Allergy, & ImmunologyAstraZenecaCompletedSystemic Lupus ErythematosusUnited States
-
AstraZenecaCompletedBreast CancerUnited States, Brazil, United Kingdom, Germany, Austria, India
-
UNC Lineberger Comprehensive Cancer CenterRecruitingQuality of Life | Breast CancerUnited States
-
BeiGeneRecruitingBreast Cancer | Small Cell Lung Cancer | Gastric Cancer | Ovarian Cancer | Prostate Cancer | Advanced Solid Tumor | Endometrial Cancer | Hormone Receptor Positive HER-2 Negative Breast Cancer | Hormone-receptor-positive Breast CancerUnited States, Australia
-
UNICANCERNovartis; Breast Cancer Research FoundationRecruiting
-
Blueprint Medicines CorporationRecruitingGastric Cancer | Ovarian Cancer | Carcinosarcoma | Advanced Solid Tumors | Endometrial Cancer | Esophageal Adenocarcinoma | HER2-negative Breast Cancer | CCNE1 Amplification | HR+ Breast CancerUnited States, Italy, United Kingdom
-
University of California, IrvineEli Lilly and CompanyTerminatedBreast Neoplasm | Hormone Receptor Positive Breast CarcinomaUnited States
-
LEO PharmaCompletedAtopic DermatitisUnited States, Belgium, Canada, Australia, France, Germany, Japan, Netherlands, Poland, United Kingdom
-
Guang'anmen Hospital of China Academy of Chinese...Hubei Hospital of Traditional Chinese Medicine; Hebei Yiling Hospital; The First... and other collaboratorsUnknown
-
Resverlogix CorpNot yet recruiting
-
Fengmei LianGuang'anmen Hospital of China Academy of Chinese Medical Sciences; Hubei Hospital... and other collaboratorsUnknownType2 Diabetes | Diabetic Non-proliferative Retinopathy
-
John Paul II Hospital, KrakowNational Center for Research and Development, Poland; KCRICompleted
-
Carrick Therapeutics LimitedCompletedAdvanced Solid MalignanciesUnited States, United Kingdom
-
G1 Therapeutics, Inc.Active, not recruitingBreast Cancer | Breast Neoplasm | Carcinoma, Ductal, BreastUnited Kingdom, Bulgaria, Georgia, Moldova, Republic of
-
Hoffmann-La RocheTerminatedBreast CancerUnited States, Brazil, Australia, Canada, Japan, Korea, Republic of, Spain, United Kingdom
-
Elevation OncologyTerminatedMetastatic Breast CancerGermany, Spain, United States, Austria, Belgium, Canada
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Withdrawn
-
Merus N.V.CompletedBreast Cancer MetastaticUnited States, France, Belgium, Spain, United Kingdom, Netherlands, Portugal
-
Adrienne G. WaksEli Lilly and Company; Verastem, Inc.RecruitingBreast Cancer | Hormone Receptor-positive Breast Cancer | Hormone Receptor Positive HER-2 Negative Breast CancerUnited States
-
Lederle LaboratoriesCompletedHIV Infections | Sarcoma, KaposiUnited States
-
Bristol-Myers SquibbActive, not recruitingPsoriatic ArthritisUnited States, Australia, Belgium, Spain, Argentina, China, Canada, Colombia, Czechia, Germany, Hungary, Italy, Japan, Mexico, Poland, Russian Federation, Taiwan, United Kingdom
-
Fudan UniversityRecruitingBreast Cancer | Advanced Breast CancerChina
-
UNICANCERRecruiting
-
Shengjing HospitalCompletedConstipation | Chinese Herbal MedicineChina
-
Novartis PharmaceuticalsTerminated
-
OnKure, Inc.RecruitingBreast Cancer | Advanced CancerUnited States, Spain
-
AstraZenecaCompleted
-
Alexandria UniversityNot yet recruiting
-
PfizerArvinas Estrogen Receptor, Inc.RecruitingAdvanced Breast CancerChina, Japan, United States, Taiwan, Canada, Korea, Republic of, Spain, Bulgaria, Turkey, Finland, Italy, Czechia, India, Slovakia, South Africa, Germany, Australia, Brazil, Greece, Puerto Rico, Belgium, Argentina, Switzerland, Poland, ... and more
-
Arak University of Medical SciencesNot yet recruiting
-
National Cancer Institute (NCI)CompletedRecurrent Breast Carcinoma | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive | HER2 Positive Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7United States
-
Translational Oncology Research InternationalUniversity of California, Los Angeles; AstraZeneca; Genentech, Inc.Terminated
-
Genzyme, a Sanofi CompanyTerminated
-
Risen (Suzhou) Pharma Tech Co., Ltd.RecruitingAdvanced Solid TumorsChina